Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Judit C. Sagi"'
Autor:
Peter Balicza, Andras Gezsi, Mariann Fedor, Judit C. Sagi, Aniko Gal, Noemi Agnes Varga, Maria Judit Molnar
Publikováno v:
Frontiers in Psychiatry, Vol 14 (2024)
We present a male patient carrying a pathogenic MECP2 p. Arg179Trp variant with predominant negative psychiatric features and multilevel evidence of mitochondrial dysfunction who responded to the cariprazine treatment. He had delayed speech developme
Externí odkaz:
https://doaj.org/article/dbee1aee261740828aabf8ee2e9df22f
Autor:
Andrea Rzepiel, Anna Horváth, Nóra Kutszegi, András Gézsi, Judit C. Sági, Laura Almási, Bálint Egyed, Péter Lőrincz, Tamás Visnovitz, Gábor T. Kovács, Csaba Szalai, Ágnes F. Semsei, Dániel J. Erdélyi
Publikováno v:
Molecular and Cellular Probes, Vol 67, Iss , Pp 101893- (2023)
Background: Minimal residual disease (MRD) is one of the most valuable independent prognostic factors in acute lymphoblastic leukemia (ALL). Bone marrow (BM) aspiration, however, is an invasive process. Previous studies have shown that microRNAs (miR
Externí odkaz:
https://doaj.org/article/7887748bf61b40a6857fee81c87f6256
Autor:
Bálint Egyed, Nóra Kutszegi, Judit C. Sági, András Gézsi, Andrea Rzepiel, Tamás Visnovitz, Péter Lőrincz, Judit Müller, Marianna Zombori, Csaba Szalai, Dániel J. Erdélyi, Gábor T. Kovács, Ágnes F. Semsei
Publikováno v:
Journal of Translational Medicine, Vol 18, Iss 1, Pp 1-12 (2020)
Abstract Background Refractory central nervous system (CNS) involvement is among the major causes of therapy failure in childhood acute leukemia. Applying contemporary diagnostic methods, CNS disease is often underdiagnosed. To explore more sensitive
Externí odkaz:
https://doaj.org/article/7e0411fad4d44a358819f5d941e51baa
Autor:
Andrea Rzepiel, Nóra Kutszegi, András Gézsi, Judit C. Sági, Bálint Egyed, György Péter, Henriett Butz, Gábor Nyírő, Judit Müller, Gábor T. Kovács, Csaba Szalai, Ágnes F. Semsei, Dániel J. Erdélyi
Publikováno v:
Journal of Translational Medicine, Vol 17, Iss 1, Pp 1-16 (2019)
Abstract Background Treatment stratification based on bone marrow minimal residual disease (MRD) at set time points has resulted in considerably improved survival in pediatric acute lymphoblastic leukemia (ALL). Treatment response is assessed using b
Externí odkaz:
https://doaj.org/article/ac8a0bda736340688e1856e1edc3ed4e
Autor:
Judit C. Sági, Bálint Egyed, Andrea Kelemen, Nóra Kutszegi, Márta Hegyi, András Gézsi, Martina Ayaka Herlitschke, Andrea Rzepiel, Lili E. Fodor, Gábor Ottóffy, Gábor T. Kovács, Dániel J. Erdélyi, Csaba Szalai, Ágnes F. Semsei
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-14 (2018)
Abstract Background The treatment of acute lymphoblastic leukemia (ALL) and osteosarcoma (OSC) is very effective: the vast majority of patients recover and survive for decades. However, they still need to face serious adverse effects of chemotherapy.
Externí odkaz:
https://doaj.org/article/bb7ab0e3755249b8b06f75269a0b8ea8
Autor:
Nóra Kutszegi, Xiaoqing Yang, András Gézsi, Géza Schermann, Dániel J. Erdélyi, Ágnes F. Semsei, Krisztina M. Gábor, Judit C. Sági, Gábor T. Kovács, András Falus, Hongyun Zhang, Csaba Szalai
Publikováno v:
Haematologica, Vol 102, Iss 9 (2017)
Hypersensitivity reactions are the most frequent dose-limiting adverse reactions to Escherichia coli-derived asparaginase in pediatric acute lymphoblastic leukemia (ALL) patients. The aim of the present study was to identify associations between sequ
Externí odkaz:
https://doaj.org/article/82087caef2774188b08a13c775c459b3